Case Study: US Based Pharmaceutical Company unlocks new growth opportunities in cardiovascular drugs with Quantzig's patient journey mapping

Leveraging Patient Journey Mapping to Uncover New Insights & Explore Future Growth Opportunities Within the Cardiovascular Drugs Segment

Quantzig worked with a US Based Pharmaceutical Company that wanted to explore future growth opportunities in the cardiovascular drugs segment. Facing plateaued performance and intense competition, the company needed a better understanding of patient journeys, treatment pathways, and the factors influencing therapy and drug selection to support potential cardiology indications, label expansion, and a stronger launch plan.

To address this, Quantzig used a multi-step patient journey mapping and analytics approach, combining data discovery, processing, and analysis of real-world evidence from EHRs, insurance claims, medical records, and DRG data. Quantzig mapped disease progression and key transition points, uncovered unmet needs and discrepancies in provider perceptions, and helped the client prioritize trial activity and build a roadmap for targeted launch planning, product positioning, and future value propositions.